440 related articles for article (PubMed ID: 18723437)
21. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
[TBL] [Abstract][Full Text] [Related]
22. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D
Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680
[TBL] [Abstract][Full Text] [Related]
24. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
[TBL] [Abstract][Full Text] [Related]
25. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
Donohue JF; Fogarty C; Lötvall J; Mahler DA; Worth H; Yorgancioglu A; Iqbal A; Swales J; Owen R; Higgins M; Kramer B;
Am J Respir Crit Care Med; 2010 Jul; 182(2):155-62. PubMed ID: 20463178
[TBL] [Abstract][Full Text] [Related]
26. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
[TBL] [Abstract][Full Text] [Related]
27. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD.
Matthys H; Pliskevich DA; Bondarchuk OM; Malek FA; Tribanek M; Kieser M
Respir Med; 2013 May; 107(5):691-701. PubMed ID: 23478193
[TBL] [Abstract][Full Text] [Related]
28. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
[TBL] [Abstract][Full Text] [Related]
29. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease.
He ZY; Ou LM; Zhang JQ; Bai J; Liu GN; Li MH; Deng JM; MacNee W; Zhong XN
Respiration; 2010; 80(6):445-52. PubMed ID: 20881376
[TBL] [Abstract][Full Text] [Related]
30. Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
Ramos FL; Criner GJ
Curr Opin Pulm Med; 2014 Mar; 20(2):153-8. PubMed ID: 24378875
[TBL] [Abstract][Full Text] [Related]
31. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.
Kardos P; Wencker M; Glaab T; Vogelmeier C
Am J Respir Crit Care Med; 2007 Jan; 175(2):144-9. PubMed ID: 17053207
[TBL] [Abstract][Full Text] [Related]
32. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
[TBL] [Abstract][Full Text] [Related]
33. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
34. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
35. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
36. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
37. Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.
Vermeersch K; Gabrovska M; Aumann J; Demedts IK; Corhay JL; Marchand E; Slabbynck H; Haenebalcke C; Haerens M; Hanon S; Jordens P; Peché R; Fremault A; Lauwerier T; Delporte A; Vandenberk B; Willems R; Everaerts S; Belmans A; Bogaerts K; Verleden GM; Troosters T; Ninane V; Brusselle GG; Janssens W
Am J Respir Crit Care Med; 2019 Oct; 200(7):857-868. PubMed ID: 31046405
[No Abstract] [Full Text] [Related]
38. A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.
Allinson JP; Vlies BH; Brill SE; Law M; Burnside G; Finney LJ; Alves-Moreira L; Donaldson GC; Calverley PMA; Walker PP; Wedzicha JA
Am J Respir Crit Care Med; 2023 Sep; 208(5):549-558. PubMed ID: 37450935
[No Abstract] [Full Text] [Related]
39. Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.
Blasi F; Bonardi D; Aliberti S; Tarsia P; Confalonieri M; Amir O; Carone M; Di Marco F; Centanni S; Guffanti E
Pulm Pharmacol Ther; 2010 Jun; 23(3):200-7. PubMed ID: 20025989
[TBL] [Abstract][Full Text] [Related]
40. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
Wilkinson TM; Patel IS; Wilks M; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2003 Apr; 167(8):1090-5. PubMed ID: 12684248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
